Stem Cell Product Product Applications

2 applications found

Potential breakthrough treatment option for Critical Limb Ischemia (CLI)

Our First DCGI Approved Stem Cell Product: Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI (Indian FDA) for manufacturing and marketing for the treatment of Critical Limb Ischemia (CLI). Stempeucel® product has been licensed to Cipla in India. Stempeutics is seeking partnership for further clinical development and commercialization of ...

ByStempeutics Research Pvt. Ltd. based in Bangalore, INDIA

Serum Products for Mesenchymal Stem Cells Growth

Growth performance of human adipose-derived mesenchymal stem cells in media containing Simplified Platelet Lysate (SimPL) and fetal bovine serum (FBS). Cells were grown in standard DMEM/F12 basal media containing penicillin, streptomycin, and GlutaMAX™ with either 10% (v/v) FBS or 2% SimPL (left). Similarly, cells were grown in identical conditions except for the use of reduced-serum basal media (Gibco™ Advanced DMEM/F12) with either 2% FBS or 2% SimPL (right). Medias supplemented with SimPL also ...

ByAgulos Biotech, LLC based in Lake Mills, WISCONSIN (USA)

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you